Skip to Content

Tag: monoclonal antibody therapy


Also Noted

NHIA urges commercial payers to cover COVID-19 treatment 

April 7, 2021HME News Staff

ALEXANDRIA, Va. – The National Home Infusion Association is urging commercial insurance plans to implement coverage policies for COVID-19 monoclonal antibody therapy used in the home. The association also says CMS’s current administration fee of approximately $310 is insufficient to cover the costs. In a study conducted in February, NHIA determined the cost of providing the therapy is between $584 and $1,746. NHIA encourages payers to work with the home...

coronavirus outbreak, monoclonal antibody therapy, national home infusion association


Read Full Articlered right arrow icon